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Biology
In vitro Screening for Modulators 
of  Synaptic Development in a Model 
of  Fragile X Syndrome
Kelsey Barter
Mentor: Aaron DiAntonio
Fragile X Syndrome (FXS) is the most common genetic cause of intellectual disability, 
caused by an X-linked mutation in the gene Fmr1, which encodes for Fragile X Mental 
Retardation Protein (FMRP). FMRP is essential for normal cognitive development 
and function, and across species, mutations in Fmr1 drive mutant phenotypes at the 
synapse. Accordingly, the function of FMRP is highly conserved across species; FMRP 
is a translational repressor with over 800 mRNA targets identified in the mouse. In 
the absence of FMRP, loss of translational repression over target mRNAs results in 
overexpression of the respective protein products. In mammals, there are obvious and 
functionally relevant defects in the development of dendritic spines, which are the 
sites at which a neuron receives excitatory synaptic input from other neurons. Cortical 
neurons of Fmr1-knockout (KO) mice, a well-established mammalian model of FXS, 
have immature, thin dendritic spines. A virtually identical malformation of dendritic 
spines has been observed in the brains of humans who had FXS, indicating that proper 
spine development is a conserved and critical aspect of FMRP function. This phenotype 
also affects synaptic function; cortical neurons from Fmr1-KO mice are hyperexcitable. 
We developed an assay to culture Fmr1-KO mouse embryonic cortical neurons to screen 
for genetic and pharmacological manipulations that can reverse these defects. The goal is 
to discover novel genes and proteins that, when knocked down or inhibited, reverse the 
in vitro immature spine phenotype of Fmr1-KO neurons, suggesting they are normally 
targeted by FMRP. We hypothesize that overexpression of these key targets may drive 
Fmr1-KO mutant phenotypes at the synapse. FXS is a developmental and intellectual 
disorder of entirely genetic origin; because it is frequently linked and shares similarities 
to Autism Spectrum Disorders (ASD), a hit from our screen could have therapeutic 
potential for the larger class of disorders.
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